Usefulness of the MFIS-K, FSS, and FACIT-F Fatigue Scales in Korean Patients With MS, NMOSD, and MOGAD
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose Fatigue is common in demyelinating disorders of the central nervous system (CNS), including multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). We aimed to validate the usefulness of the Functional Assessment of Chronic Illness Therapy–Fatigue (FACIT-F) and the Fatigue Severity Scale (FSS) relative to the Korean version of the Modified Fatigue Impact Scale (MFIS-K) in Korean patients with MS, NMOSD, and MOGAD. Methods There were 294 patients with MS (n=120), NMOSD (n=103), or MOGAD (n=71) enrolled in a prospective demyelinating CNS registry. Fatigue was measured using the FACIT-F, MFIS-K, and FSS. Sleep quality, quality of life, depression, and pain were evaluated using the Pittsburgh Sleep Quality Index (PSQI), 36-item Short-Form Survey (SF-36), and Beck Depression Inventory-II (BDI-II). Results The MFIS-K, FACIT-F, and FSS scores showed high internal consistencies and strong correlations with each other in the MS, NMOSD, and MOGAD groups. The scores on all three fatigue scales were correlated with PSQI, SF-36, and BDI-II results in the three groups. The areas under the receiver operating characteristic curves for the FSS and FACIT-F were 0.834 and 0.835, respectively, for MS, 0.877 and 0.833 for NMOSD, and 0.925 and 0.883 for MOGAD. Conclusions These results suggest that the MFIS-K, FSS, and FACIT-F are useful and valuable assessment instruments for evaluating fatigue in Korean patients with MS, NMOSD, and MOGAD.
Abstract
Background and Purpose Fatigue is common in demyelinating disorders of the central nervous system (CNS), including multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). We aimed to validate the usefulness of the Functional Assessment of Chronic Illness Therapy–Fatigue (FACIT-F) and the Fatigue Severity Scale (FSS) relative to the Korean version of the Modified Fatigue Impact Scale (MFIS-K) in Korean patients with MS, NMOSD, and MOGAD. Methods There were 294 patients with MS (n=120), NMOSD (n=103), or MOGAD (n=71) enrolled in a prospective demyelinating CNS registry. Fatigue was measured using the FACIT-F, MFIS-K, and FSS. Sleep quality, quality of life, depression, and pain were evaluated using the Pittsburgh Sleep Quality Index (PSQI), 36-item Short-Form Survey (SF-36), and Beck Depression Inventory-II (BDI-II). Results The MFIS-K, FACIT-F, and FSS scores showed high internal consistencies and strong correlations with each other in the MS, NMOSD, and MOGAD groups. The scores on all three fatigue scales were correlated with PSQI, SF-36, and BDI-II results in the three groups. The areas under the receiver operating characteristic curves for the FSS and FACIT-F were 0.834 and 0.835, respectively, for MS, 0.877 and 0.833 for NMOSD, and 0.925 and 0.883 for MOGAD. Conclusions These results suggest that the MFIS-K, FSS, and FACIT-F are useful and valuable assessment instruments for evaluating fatigue in Korean patients with MS, NMOSD, and MOGAD.
참고문헌 (37)
- Bergamaschi R, "Clinical aspects of fatigue in multiple sclerosis", Funct Neurol, 12, pp.247~251 (1997)
- Seok JM, "Fatigue in patients with neuromyelitis optica spectrum disorder and its impact on quality of life", PLoS One, 12, pp.e0177230~ (2017)
- Ladakis DC, "Fatigue is a common symptom in myelin oligodendrocyte glycoprotein antibody disease", Mult Scler J Exp Transl Clin, 8, pp.20552173221131235~ (2022)
- Cohen ET, "Self-report measures of fatigue for people with multiple sclerosis : a systematic review", J Neurol Phys Ther, 48, pp.6~14 (2024)
- Delgado-Álvarez A, "Validation of two new scales for the assessment of fatigue in multiple sclerosis : F-2-MS and FACIT-F", Mult Scler Relat Disord, 63, pp.103826~ (2022)
- Masuda H, "Validation of the modified fatigue impact scale and the relationships among fatigue, pain and serum interleukin-6 levels in patients with neuromyelitis optica spectrum disorder", J Neurol Sci, 385, pp.64~68 (2018)
- Yamamura T, "Trial of satralizumab in neuromyelitis optica spectrum disorder", N Engl J Med, 381, pp.2114~2124 (2019)
- Yeo T, "Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies", Ann Clin Transl Neurol, 7, pp.375~383 (2020)
- Chavarro VS, "Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder", Neurol Neuroimmunol Neuroinflamm, 3, pp.e286~ (2016)
- Camera V, "Shared imaging markers of fatigue across multiple sclerosis, aquaporin-4 antibody neuromyelitis optica spectrum disorder and MOG antibody disease", Brain Commun, 5, pp.fcad107~ (2023)
- Chung YH, "Validity and reliability of Korean version of modified fatigue impact scale(MFIS)for Korean patients with multiple sclerosis", Mult Scler Relat Disord, 62, pp.103811~ (2022)
- Kim W, "Validation of the Korean version of the 12-item multiple sclerosis walking scale and application to neuromyelitis optica spectrum disorder", J Clin Neurol, 16, pp.270~276 (2020)
- Chung KI, "Clinical usefulness of fatigue severity scale for patients with fatigue, and anxiety or depression", Korean J Psychosom Med, 9, pp.164~173 (2001)
- Lee WG, "Psychometric evaluation of the Korean version of the functional assessment of chronic illness therapy-fatigue", J Nurs Res, 30, pp.e206~ (2022)
- Thompson AJ, "Diagnosis of multiple sclerosis : 2017 revisions of the McDonald criteria", Lancet Neurol, 17, pp.162~173 (2018)
- Wingerchuk DM, "International consensus diagnostic criteria for neuromyelitis optica spectrum disorders", Neurology, 85, pp.177~189 (2015)
- Kang ES, "Clinical usefulness of cell-based indirect immunofluorescence assay for the detection of aquaporin-4antibodies in neuromyelitis optica spectrum disorder", Ann Lab Med, 32, pp.331~338 (2012)
- Banwell B, "Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease : international MOGAD panel proposed criteria", Lancet Neurol, 22, pp.268~282 (2023)
- Krupp LB, "The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus", Arch Neurol, 46, pp.1121~1123 (1989)
- Fisk JD, "Measuring the functional impact of fatigue : initial validation of the fatigue impact scale", Clin Infect Dis, 18(Suppl 1), pp.S79~S83 (1994)
- Lim SY, "The validation study of Beck Depression Scale 2 in Korean version", Anxiety Mood, 7, pp.48~53 (2011)
- Sohn SI, "The reliability and validity of the Korean version of the Pittsburgh Sleep Quality Index", Sleep Breath, 16, pp.803~812 (2012)
- Ware JE, "User’s manual for the SF-12v2 health survey second edition" (2009), QualityMetric
- Yun YH, "Development of a cancer pain assessment tool in Korea : a validation study of a Korean version of the brief pain inventory", Oncology, 66, pp.439~444 (2004)
- Kang YW, "A validity study on the Korean minimental state examination(K-MMSE)in dementia patients", J Korean Neurol Assoc, 15, pp.300~308 (1997)
- Beatty WW, "Screening for cognitive impairment in multiple sclerosis. An evaluation of the mini-mental state examination", Arch Neurol, 47, pp.297~301 (1990)
- Smith A, "Symbol digit modalities test" (1991), Western Psychological Services
- Flachenecker P, "Fatigue in multiple sclerosis : a comparison of different rating scales and correlation to clinical parameters", Mult Scler, 8, pp.523~526 (2002)
- Oliva Ramirez A, "Prevalence and burden of multiple sclerosis-related fatigue : a systematic literature review", BMC Neurol, 21, pp.468~ (2021)
- Akaishi T, "Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica", J Neuroimmunol, 283, pp.70~73 (2015)
- Seok JM, "Association of subcortical structural shapes with fatigue in neuromyelitis optica spectrum disorder", Sci Rep, 12, pp.1579~ (2022)
- Shin JS, "Comparison of psychiatric disturbances in patients with multiple sclerosis and neuromyelitis optica", Medicine(Baltimore), 98, pp.e17184~ (2019)
- Hyun JW, "Increased frequency and severity of restless legs syndrome in patients with neuromyelitis optica spectrum disorder", Sleep Med, 17, pp.121~123 (2016)
- Kim JE, "Prevalence and incidence of neuromyelitis optica spectrum disorder and multiple sclerosis in Korea", Mult Scler, 26, pp.1837~1844 (2020)
- Lee HL, "Prevalence and incidence of neuromyelitis optica spectrum disorder in Korea : population based study", J Korean Med Sci, 35, pp.e115~ (2020)
- Capone F, "Fatigue in multiple sclerosis : the role of thalamus", Mult Scler, 26, pp.6~16 (2020)
- Strober LB, "Tired of not knowing what that fatigue score means? Normative data of the modified fatigue impact scale (MFIS)", Mult Scler Relat Disord, 46, pp.102576~ (2020)